Австралия - английский - Department of Health (Therapeutic Goods Administration)

vertex pharmaceuticals australia pty ltd - lumacaftor, quantity: 75 mg; ivacaftor, quantity: 94 mg - granules - excipient ingredients: croscarmellose sodium; hypromellose acetate succinate; microcrystalline cellulose; povidone; sodium lauryl sulfate - orkambi is indicated for the treatment of cystic fibrosis (cf) in patients aged 1 year and older who are homozygous for the f508del mutation in the cftr gene.

Австралия - английский - Department of Health (Therapeutic Goods Administration)

vertex pharmaceuticals australia pty ltd - ivacaftor -

Австралия - английский - APVMA (Australian Pesticides and Veterinary Medicines Authority)

agspray chemical co. pty. ltd. - 2,2-dpa; amitrole; diuron - soluble powder - 2,2-dpa acid-alkanoic active 504.0 g/kg; amitrole triazole active 110.0 g/kg; diuron urea-substituted active 160.0 g/kg - herbicide - carpark weed control | fenceline weed control | industrial land or area | tennis court | track, roadway and drain weed control - annual grass weed | broadleaf weeds | couch grass | johnson grass | kikuyu grass | nutgrass | paspalum | perennial grass weed | annual grasses | broadleaf grass | green couch | indian couch | perennial couch | plain couch | victorian nutgrass

Израиль - английский - Ministry of Health

organon pharma israel ltd., israel - finasteride - film coated tablets - finasteride 1 mg - finasteride - finasteride - propecia is indicated for the treatment of men with male pattern hair loss (androgenetic alopecia) to increase hair growth and prevent further hair loss

Австралия - английский - Department of Health (Therapeutic Goods Administration)

vertex pharmaceuticals australia pty ltd - ivacaftor, quantity: 125 mg; lumacaftor, quantity: 200 mg - tablet, film coated - excipient ingredients: hypromellose acetate succinate; sodium lauryl sulfate; microcrystalline cellulose; povidone; magnesium stearate; croscarmellose sodium; titanium dioxide; purified water; purified talc; brilliant blue fcf aluminium lake; polyvinyl alcohol; macrogol 3350; cochineal; indigo carmine aluminium lake; propylene glycol; butan-1-ol; isopropyl alcohol; strong ammonia solution; iron oxide black; ethanol; shellac; sulfuric acid - orkambi is indicated for the treatment of cystic fibrosis (cf) in patients aged 1 year and older who are homozygous for the f508del mutation in the cftr gene.

Австралия - английский - Department of Health (Therapeutic Goods Administration)

vertex pharmaceuticals australia pty ltd - ivacaftor, quantity: 150 mg - tablet, film coated - excipient ingredients: magnesium stearate; microcrystalline cellulose; croscarmellose sodium; silicon dioxide; carnauba wax; sodium lauryl sulfate; hypromellose acetate succinate; lactose monohydrate; propylene glycol; butan-1-ol; isopropyl alcohol; strong ammonia solution; iron oxide black; ethanol; shellac; sulfuric acid; titanium dioxide; purified talc; polyvinyl alcohol; macrogol 3350; indigo carmine aluminium lake - kalydeco is indicated for the treatment of cystic fibrosis (cf) in patients aged 4 months and older who have at least one mutation in the cftr gene that is responsive to ivacaftor potentiation based on clinical and/or in vitro assay data(see section 4.4 special warnings and precautions for use, and section 5.1 pharmacodynamic properties)

Великобритания - английский - MHRA (Medicines & Healthcare Products Regulatory Agency)

vertex pharmaceuticals (uk - ivacaftor - tablet - 150mg

Великобритания - английский - MHRA (Medicines & Healthcare Products Regulatory Agency)

vertex pharmaceuticals (uk - ivacaftor; lumacaftor - tablet - 125mg ; 200mg

Великобритания - английский - MHRA (Medicines & Healthcare Products Regulatory Agency)

vertex pharmaceuticals (uk - ivacaftor - granules - 50mg

Великобритания - английский - MHRA (Medicines & Healthcare Products Regulatory Agency)

vertex pharmaceuticals (uk - ivacaftor - granules - 75mg